EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis

Sai Zhu iD, Ling Jiang iD, Xinran Liu iD, Chaoyi Chen iD, Xiaomei Luo iD, Shan Jiang iD, Jiuyu Yin iD, Xueqi Liu iD, Yonggui Wu iD

The FASEB Journal · 31.01.2025 · 39 (2)

DOI: 10.1096/fj.202403014r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.01.2025. Verfasst von Sai Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, People's Republic of Ch…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Glycolysis, Macrophage Activation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The National Science Foundation of China, The National Natural Science Foundation of China, Basic and Clinical Improvement Program of Anhui Meducal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophage infiltration and activation is a key factor in the progression of diabetic nephropathy (DN). However, aerobic glycolysis induced by m6A methylation modification plays a key role in M1‐type activation of macrophages, but the specific mechanism remains unclear in DN. In this study, the expression of m6A demethylase Fto in bone marrow derived macrophages and primary kidney macrophages from db/db mice. Loss and gain‐of‐function analysis of Fto were performed to assess the role of Fto in DN. Transcriptome and MeRIP‐seq association analysis was performed to identified the target gene was Npas2. In this study, we found that demethylase Fto exhibits low expression in type 2 DN m6A modification of Npas2 mediated by Fto regulates macrophages M1‐type activation and glucose metabolism reprogramming to participate in the process of DN. Furthermore, Fto reduces the m6A modification level of Npas2 in macrophages through a Prrc2a‐dependent mechanism, and decreasing its stability. This process mediates inflammation and glycolysis in M1 macrophages by regulating the Hif‐1α signaling pathway. Fto may act as a suppressor of M1 macrophages inflammation and glycolysis in DN through the m6A/Npas2/Hif‐1α axis. This findings providing a new basis for the prevention and treatment of DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesAlpha-Ketoglutarate-Dependent Dioxygenase FTOGlycolysisMacrophage ActivationBasic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha SubunitNerve Tissue ProteinsAnimalsMiceMacrophagesMaleMice, Inbred C57BLSignal TransductionEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

FtoN6‐methyladenosineNpas2Prrc2aglycolysismacrophage

Substanzen

Alpha-Ketoglutarate-Dependent Dioxygenase FTOBasic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha SubunitNerve Tissue ProteinsEndothelial PAS Domain-Containing Protein 1FTO protein, mouseHif1a protein, mouse

Autor:innen und Institutionen

  • Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Center for Scientific Research of Anhui Medical University, Hefei, Anhui, People's Republic of China.

ORCID-Profile: Sai Zhu, Ling Jiang, Xinran Liu, Chaoyi Chen, Xiaomei Luo, Shan Jiang, Jiuyu Yin, Xueqi Liu, Yonggui Wu

Förderung

  • The National Science Foundation of China
  • The National Natural Science Foundation of China
  • Basic and Clinical Improvement Program of Anhui Meducal University
  • 2022 Anhui Provincial Department of Education University research project
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, S., Jiang, L., Liu, X., Chen, C., Luo, X., Jiang, S., Yin, J., Liu, X., & Wu, Y. (2025). m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis. The FASEB Journal, 39(2). https://doi.org/10.1096/fj.202403014r

Vancouver

Zhu S, Jiang L, Liu X, Chen C, Luo X, Jiang S, et al. m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis. The FASEB Journal. 2025;39(2). doi:10.1096/fj.202403014r

BibTeX
@article{Zhu2025,
  author = {Zhu, Sai and Jiang, Ling and Liu, Xinran and Chen, Chaoyi and Luo, Xiaomei and Jiang, Shan and Yin, Jiuyu and Liu, Xueqi and Wu, Yonggui},
  title = {m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {2},
  doi = {10.1096/fj.202403014r}
}
Kostenlos starten →